Cargando…
GBA1-dependent membrane glucosylceramide reprogramming promotes liver cancer metastasis via activation of the Wnt/β-catenin signalling pathway
The effect of glucosylceramide (GlcCer) reprogramming on liver cancer metastasis remains poorly understood. In this study, we demonstrated that the protein expression of GBA1, which catalyses the conversion of GlcCer to ceramide, was downregulated in liver cancer tissue. A clinical relevance analysi...
Autores principales: | Qiu, Zhidong, Wang, Xuehong, Yang, Zebin, Liao, Sicong, Dong, Wei, Sun, Tian, Wu, Huixian, Zhang, Qinqin, Pan, Zhixiong, Lam, Sin Man, Shui, Guanghou, Jin, Junfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151913/ https://www.ncbi.nlm.nih.gov/pubmed/35637196 http://dx.doi.org/10.1038/s41419-022-04968-6 |
Ejemplares similares
-
Accumulation of Glucosylceramide in the Absence of the Beta-Glucosidase GBA2 Alters Cytoskeletal Dynamics
por: Raju, Diana, et al.
Publicado: (2015) -
Preclinical pharmacology of glucosylceramide synthase inhibitor venglustat in a GBA-related synucleinopathy model
por: Viel, Catherine, et al.
Publicado: (2021) -
Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI
por: Huh, Young Eun, et al.
Publicado: (2021) -
S1PR1 induces metabolic reprogramming of ceramide in vascular endothelial cells, affecting hepatocellular carcinoma angiogenesis and progression
por: Wang, Xuehong, et al.
Publicado: (2022) -
Metabolomics, a Powerful Tool for Agricultural Research
por: Tian, He, et al.
Publicado: (2016)